Originally targeted 2015 finish
Our series continues
Article six in our platform series
Ascentric, James Hay and Nucleus have all made changes
Platform functionality highlights
'Deliberately simplistic', firm says
Rising property prices could land many with IHT liabilities
Investors are getting dismal interest rates when they hold cash on the UK's biggest advised platforms, with some actually making a loss after fees, an investigation by Professional Adviser has found.
Fidelity FundsNetwork is to make Neil Woodford's Patient Capital trust the first externally-managed investment trust available on the platform, in what it says is a "clear intention" of more to come.
Transact is to cut platform fees for client portfolios of between £180,000 and £300,000 in an attempt to attract new business.
Ascentric has introduced an inclusive platform charge as it moves to give advisers more charging options for their clients.
Ascentric managing director Hugo Thorman is to leave the firm this summer following Royal London's buyout of the platform's minority shareholding in the business.
Ascentric's managing director, Hugo Thorman, has argued advisers' use of model portfolios is hindering the popularity of investment trusts.
Ascentric has posted a £0.6m loss for the 2013 financial year after "significant" investment in technology which cost it £1.6m.
Jon Taylor, head of the former Co-op life insurance business, is to replace Hugo Thorman as managing director of platform Ascentric.
Platform Ascentric has removed the set up and transfer-in costs on its in-house self invested personal pension (SIPP) and cut its annual tax wrapper fee from £150 to £100.
Is time running out for advisers looking to dip their toe in execution only?
Henry Brennan finds out what the D2C price war could mean for market sustainabilty
Charles Stanley has rolled out its Collectives Portfolio Service to five platforms.
Royal London Asset Management (RLAM) has reported a record year for external new business in 2013, with gross inflows up almost 70%, a highlight in a strong set of results for its life company parent.
A record year to date performance has taken Ascentric and IFDL past the £7bn milestone for assets under administration.